Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

CDLX Cardlytics, Inc. Common Stock
$1.01 0.00% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy CDLX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 55.1M
Enterprise value 233.2M
Trailing PE -0.26086956033926
Forward PE -3.358659
PEG Ratio 0.0049124787336614
Enterprise to EBITDA -9.385
Enterprise to revenue 0.928
Price to book MRQ -11.59924723208
Price to sales TTM 0.22167112

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 251.2M
EBITDA -24843000
Diluted EPS TTM -2.06
Total Cash (MRQ) 44.0M
Current ratio (MRQ) 1.137
Operating Cash Flow (TTM) -741000

CDLX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months
Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.